IL-22 Binding Protein Promotes the Disease Process in Multiple Sclerosis

^*Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, 17177 Stockholm, Sweden;
^†Department of Medical Sciences, Rheumatology and Science for Life Laboratories, Uppsala University, 75105 Uppsala, Sweden;
^‡Respiratory, Inflammation and Autoimmunity Research, MedImmune, Cambridge CB21 6GH, United Kingdom;
^§High Content Imaging, MedImmune, Cambridge CB21 6GH, United Kingdom; and
^¶Institute of Environmental Medicine, Karolinska Institutet, 17177 Stockholm, Sweden

Address correspondence and reprint requests to Dr. Hannes Lindahl, CMM L8:04, Karolinska University Hospital, 17176 Stockholm, Sweden. E-mail address: hannes.lindahl{at}ki.se

H.L., A.O.G.-C., M.J., and T.O. contributed to experimental design. K.T. and N.A. performed sample collection. H.L., A.O.G.-C., S.K.B., M. Linnerbauer, M. Lindén, C.H., C.J., L.I., C.G., and M.K. performed experiments, data collection, and data analysis. H.L. wrote the manuscript. H.L., A.O.G.-C., S.K.B., M. Linnerbauer, M. Lindén, N.A., L.A., L.R., I.K., M.K., M.J., and T.O. edited the manuscript.